US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle

      Summary Company Announcement Date: March 23, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / FDA Announces Class I Recalls of Two Unapproved Devices

FDA Announces Class I Recalls of Two Unapproved Devices

December 16, 2008 By The FDA Leave a Comment

THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) ANNOUNCED A CLASS 1 RECALL TODAY FOR TWO UNAPPROVED AND UNCLEARED DEVICES WHOSE MANUFACTURERS CLAIMED COULD TREAT VARIOUS MEDICAL CONDITIONS. A CLASS 1 RECALL MEANS THAT THERE IS A REASONABLE PROBABILITY THAT THE USE OF A DEVICE WILL CAUSE ADVERSE HEALTH CONSEQUENCES OR DEATH.

THE MANUFACTURERS, VIBE TECHNOLOGIES OF GREELEY, COLO., AND NEBION LLC OF LOS ANGELES, CALIF., CLAIMED THEIR DEVICES TREATED CONDITIONS RANGING FROM CANCER TO MIGRAINES. THE FDA IS CONCERNED THAT BASED UPON THE ORIGINAL HEALTH CLAIMS MADE BY THE COMPANY, PATIENTS MAY FORGO APPROVED THERAPIES, AND THAT THIS COULD RESULT IN MORE SEVERE ILLNESS OR DEATH.

"THESE RECALLS UNDERSCORE THE IMPORTANCE OF TAKING ACTION AGAINST MANUFACTURERS WHO MAKE FALSE MEDICAL CLAIMS FOR THEIR DEVICES," SAID DANIEL G. SCHULTZ, M.D., DIRECTOR OF THE FDA’S CENTER FOR DEVICES AND RADIOLOGICAL HEALTH. "ONE OF THE FDA’S PRIMARY RESPONSIBILITIES IS PROTECTING CONSUMERS FROM HARM THAT CAN BE CAUSED BY MANUFACTURERS WHO TRY TO SIDESTEP THE APPROVAL AND CLEARANCE PROCESS.”

VIBRATIONAL INTEGRATED BIO-PHOTONIC ENERGIZER DEVICE

ON APRIL 11, 2008, THE FDA ISSUED A WARNING LETTER TO VIBE TECHNOLOGIES STATING THAT THE AGENCY’S NOVEMBER 2007 INSPECTION OF THE FACILITY SHOWED THAT THE COMPANY HAD NOT OBTAINED FDA MARKETING APPROVAL OR CLEARANCE FOR THE VIBRATIONAL INTEGRATED BIO-PHOTONIC ENERGIZER (VIBE DEVICE), WHICH CLAIMS TO TREAT CANCER, INFECTIONS, AND DEPRESSION. THE FDA ALSO CITED THE COMPANY FOR SUBSTANTIAL DEVIATIONS FROM THE CURRENT GOOD MANUFACTURING PRACTICE/QUALITY SYSTEM REGULATION.

VIBE TECHNOLOGIES INITIATED A RECALL OF 840 VIBE DEVICES IN AN APRIL 3, 2008, LETTER SENT TO USERS. VIBE TECHNOLOGIES AGREED TO STOP PROMOTING AND MARKETING THE VIBE DEVICE, AND WILL CONTACT ALL THOSE WHO HAD PURCHASED IT TO ENSURE NO OTHER UNSUBSTANTIATED MEDICAL CLAIMS ARE BEING MADE. THE FDA HAS REQUESTED THAT THE COMPANY UPDATE ITS RECALL NOTICES TO STATE THAT THE VIBE DEVICE IS NOT INTENDED FOR THE TREATMENT OF ANY DISEASES OR MEDICAL CONDITIONS.

THE FDA IS AWARE OF INFORMATION THAT SUGGESTS THAT THE VIBE DEVICE HAS BEEN USED IN CANCER PATIENTS. THERE IS ONE DEATH THAT OCCURRED IN A PATIENT WHO USED THIS DEVICE.  HOWEVER, FDA HAS NOT VERIFIED THAT THERE IS ANY ASSOCIATION BETWEEN THE DEATH AND THE VIBE DEVICE.

HLX8 DEVICE

IN JUNE 2008 FDA INSPECTED NEBION, LLC, WHICH REVEALED THAT THE COMPANY HAD NOT OBTAINED FDA MARKETING APPROVAL OR CLEARANCE FOR THE HLX8 DEVICE, WHICH CLAIMS TO TREAT CANCER, MIGRAINES, ARTHRITIS, AND RUPTURED DISCS. THE INSPECTION ALSO UNCOVERED SUBSTANTIAL DEVIATIONS FROM THE CURRENT GOOD MANUFACTURING PRACTICE/QUALITY SYSTEM REGULATION.

NEBION RECALLED EIGHT HLX8 DEVICES ON JULY 2, 2008, AND NOTIFIED THEIR CUSTOMERS TO STOP USING THE DEVICES IMMEDIATELY AND TO CONTACT NEBION FOR THEIR RETRIEVAL.

NEBION’S FIRST RECALL LETTER DID NOT ADDRESS THE POTENTIAL RISKS ASSOCIATED WITH THE HLX8 DEVICE, BUT THE COMPANY HAS RECENTLY NOTIFIED FDA THAT THEY WILL ISSUE A SECOND LETTER THAT IDENTIFIES POTENTIAL HEALTH HAZARDS. THE FDA HAS NOT RECEIVED ANY REPORTS OF INJURIES OR DEATHS LINKED WITH THE HLX8 DEVICE.

UNDER FEDERAL LAW, PRODUCTS THAT CLAIM TO DIAGNOSE A DISEASE OR CONDITION, CURE, MITIGATE, TREAT OR PREVENT DISEASE, OR THAT ARE INTENDED TO AFFECT THE STRUCTURE OR FUNCTION OF THE BODY ARE DEVICES SUBJECT TO FDA JURISDICTION AND MAY REQUIRE FDA APPROVAL OR CLEARANCE PRIOR TO MARKETING. PREMARKET APPROVAL IS THE MOST STRINGENT TYPE OF FDA DEVICE REVIEW AND IS FOR DEVICES WITH A HIGH LEVEL OF RISK, SUCH AS THOSE THAT SUPPORT OR SUSTAIN HUMAN LIFE. FDA CLEARANCE IS FOR LOWER RISK DEVICES THAT ARE SHOWN TO BE AS SAFE AND EFFECTIVE AS A SIMILAR DEVICE ALREADY ON THE MARKET.

NEITHER VIBE TECHNOLOGIES NOR NEBION HAS DEMONSTRATED TO THE FDA THAT THEIR DEVICE IS SAFE AND EFFECTIVE AT CURING OR TREATING DISEASES AS CLAIMED.

HEALTH CARE PROFESSIONALS AND CONSUMERS MAY REPORT SERIOUS ADVERSE EVENTS (SIDE EFFECTS) OR PRODUCT QUALITY PROBLEMS WITH THE USE OF THIS PRODUCT TO THE FDA’S MEDWATCH ADVERSE EVENT REPORTING PROGRAM EITHER ONLINE, BY REGULAR MAIL, FAX OR PHONE.

ONLINE: WWW.FDA.GOV/MEDWATCH/REPORT.HTM REGULAR MAIL: USE POSTAGE-PAID FDA FORM 3500 AVAILABLE AT: WWW.FDA.GOV/MEDWATCH/GETFORMS.HTM AND MAIL TO MEDWATCH, 5600 FISHERS LANE, ROCKVILLE, MD 20852-9787 FAX: (800) FDA-0178 PHONE: (800) FDA-1088

HEALTH CARE PROFESSIONALS AND PATIENTS CAN OBTAIN FURTHER DETAILS ABOUT THE RECALLS FROM VIBE TECHNOLOGIES AT 970-356-9594 OR NEBION LLC, AT 310-215-6400.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle

March 23, 2023 By The FDA

Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards

March 22, 2023 By The CPSC

Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)

March 22, 2023 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”

March 21, 2023 By The FDA

Mutual Trading Co., Inc Issues Allergy Alert for Undeclared Soy in Sauces

March 20, 2023 By The FDA

Voluntary Recall of One Lot of Kaytee® Wild Bird Food Birders Blend, 8 Lb Bag, Due to Elevated Levels of Aflatoxin

March 18, 2023 By The FDA

Perrigo Announces Voluntary Recall of Limited Quantity of Gerber® Good Start® SootheProTM Powdered Infant Formula

March 16, 2023 By The FDA

Mockingbird Expands Recall to Include Single Strollers Due to Fall Hazard

March 16, 2023 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Perrigo Announces Voluntary Recall of Limited Quantity of Gerber® Good Start® SootheProTM Powdered Infant Formula

March 16, 2023 By The FDA

Mockingbird Expands Recall to Include Single Strollers Due to Fall Hazard

March 16, 2023 By The CPSC

Updated – Scenic Fruit Company Recalls Frozen Organic Strawberries and Frozen Organic Tropical Blend Because of Possible Health Risk

March 15, 2023 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle
  • Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards
  • Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)
  • Textron Specialized Vehicles Recalls Arctic Cat Alterra 600 and
    Tracker 600 All-Terrain Vehicles (ATVs) Due to Crash Hazard
    (Recall Alert)
  • Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
  • Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”
  • Mutual Trading Co., Inc Issues Allergy Alert for Undeclared Soy in Sauces
  • Voluntary Recall of One Lot of Kaytee® Wild Bird Food Birders Blend, 8 Lb Bag, Due to Elevated Levels of Aflatoxin
  • Perrigo Announces Voluntary Recall of Limited Quantity of Gerber® Good Start® SootheProTM Powdered Infant Formula
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in